immunized
[대역어] None
[용어속성] Action
[용어속성] Action
The Adjuvanticity of an O. volvulus -Derived r Ov -ASP-1 Protein in Mice Using Sequential Vaccinations and in Non-Human Primates
Research Article
[키워드] Activation
adjuvant
adjuvanticity
administration
anti-RBD
antibody
Antibody Response
antigens
bystander
Course
DC
different
Effectiveness
Efficacy
element
first vaccination
functional
host response
IFN-γ
IgG2a
IL-2
IL-6
immunized
induce
Influenza virus
maturation
mice
naïve
NHPs
non-human primate
not affect
Onchocerca volvulus
primate
promote
promoted
Protective
protective immune response
Protein
provided
RBD
reported
retained
SARS-CoV spike protein
sera
subsequent
Th1
Th1 cytokines
Th2 response
the receptor-binding domain
titre
TNF-α
upregulated
utility
vaccination
Vaccine
vaccine antigen
virus strains
was used
[DOI] 10.1371/journal.pone.0037019 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pone.0037019 PMC 바로가기 [Article Type] Research Article
Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV
Research article
[키워드] acute respiratory syndrome
analyzed
assays
autologous
binding
Candidates
Cell-mediated immune responses
cleavage
conserved
coronavirus
CoV
CTL
dendritic cell
different
Donor
eight
epitope
Ex vivo
full-length S protein
glycoprotein
healthy
help
identification
IFN-γ
immunized
immunized mice
immunopathology
lysed
mechanism
Pathogenesis
PBL
peptide
peptides
Plasmid
predict
processed
Protein
Region
released
Result
S protein
SARS-CoV
SARS-CoV infection
sequence
target cell
tested
the S protein
the spike protein
transgenic mice
virus
virus clearance
[DOI] 10.1186/1471-2172-10-61 PMC 바로가기 [Article Type] Research article
[DOI] 10.1186/1471-2172-10-61 PMC 바로가기 [Article Type] Research article
Vaccine Efficacy in Senescent Mice Challenged with Recombinant SARS-CoV Bearing Epidemic and Zoonotic Spike Variants
Research Article
[키워드] 2003
acute respiratory syndrome
addition
Administered
Antisera
bat
bats
Bearing
candidate vaccine
caused
Cell
cellular immune responses
center
characterized
chimeric
China
Cluster
coding
Complete
Consequences
Control
coronavirus
cross
death
death rate
death rates
develop
died
different
disease
effective
Efficacy
eight
elicit
Epidemic
etiological agent
examined
expressing
finding
flu
found
future infection
Gene
genetic material
genetics
glycoprotein
group
Guidance
Heterologous
heterologous challenge
homologous
homologous or heterologous
homologous strain challenge
Human
human airway epithelial
humans
identify
immune response
immunized
immunopathology
infect
Infected
Infection
information
injected
lung
mice
much higher
neutralization
nucleocapsid
Older
Outbreaks
Particle
pathological change
pathology
peaked
phylogenetic analyses
populations
PROTECT
Protein
Proteins
provide
provided
recombinant
related virus
related viruses
replicated
researcher
reservoirs
resource
robust
rodents
S glycoprotein
SARS Coronavirus
SARS infection
SARS virus
SARS-CoV
SARS-CoV N
SARS-CoV S
SARS-CoV S protein
SARS-CoV vaccine
SARS-CoV virus
senescent
severe
severe pneumonia
spike
spike glycoprotein
Spread
strain
Strains
tested
the disease
the vaccine
thought
vaccination
Vaccine
vaccine candidate
Vaccine design
Vaccine development
Vaccines
variant
Venezuelan equine encephalitis
virus
virus
virus strain
was used
Web
West Nile Virus
World Health Organization
zoonosis
zoonotic
[DOI] 10.1371/journal.pmed.0030525 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pmed.0030525 PMC 바로가기 [Article Type] Research Article